As winter peaks, China is experiencing a sharp rise in flu and respiratory illnesses, leading to overcrowded hospitals. Viral videos on social media showing packed medical facilities have sparked concerns about a potential outbreak.
Human Metapneumovirus (HMPV) Identified as Cause
The respiratory illness has been traced to Human Metapneumovirus (HMPV), spreading rapidly in northern China, primarily affecting children and the elderly. Beijing has dismissed global concerns, attributing the situation to typical seasonal trends, while nations closely monitor the outbreak.
Read more: India Reports First Confirmed Cases of (HMPV) Amid Global Surge
What is HMPV?
HMPV is a respiratory virus first discovered in 2001, causing cold-like symptoms such as cough, fever, and sore throat. While generally mild, it can lead to severe complications like pneumonia, particularly in infants, the elderly, and those with weak immune systems. The virus spreads via respiratory droplets or contact with contaminated surfaces.
Symptoms and High-Risk Groups
HMPV symptoms include cough, blocked nose, fever, and, in severe cases, wheezing and breathing difficulties. Infants under one, older adults, and immunocompromised individuals are at greater risk of severe respiratory infections.
Treatment and Prevention
Currently, there is no vaccine or antiviral treatment for HMPV. Management focuses on symptom relief, including rest, hydration, and fever-reducing medication. Preventive measures such as regular handwashing, mask-wearing in crowded areas, and avoiding touching the face are recommended.
Health Advisory
Experts advise that while most recover in 3 to 6 days, high-risk individuals should remain vigilant and seek medical help if symptoms worsen. Chinese authorities are enhancing monitoring systems to control the virus’s spread, while global health organizations observe the situation closely.
